Reset Health, the experts in the personalised management of chronic disease, has entered a strategic partnership with Pharmacy2U, the UK’s largest online pharmacy, to deliver next-generation digital weight management support to patients using weight loss medication across the UK.

Reset Health, the experts in the personalised management of chronic disease, today announces Pinder Sahota has joined the Company as a member of its Advisory Board.

Obesity and depression are deeply interconnected, yet few programmes effectively address both in tandem. The Roczen Programme, developed by Reset Health Ltd., offers a fresh, clinically grounded approach.

Reset Health is pleased to announce that Professor Sir Jonathan Van-Tam has joined Reset Health as a member of its Advisory Board.

Rochelle brings over 20 years of leadership experience in healthcare, spanning clinical innovation, digital transformation, and strategic product development.

Nearly 26% of adult Britons live with obesity and this number is expected to rise to 37% by 2030.

Obesity and type 2 diabetes (T2D) remain major global health challenges. Continuous energy restriction can help people lose weight, but more recently time-restricted eating (TRE) has been shown to be an alternative method for weight loss.

Obesity is a growing problem in the UK, affecting more and more people and putting a strain on both individuals and the healthcare system.

We’re delighted to welcome David Plans who has joined Reset Health as Chief Scientific Officer (CSO).

Reset Health is pleased to announce the appointment of Sarah Le Brocq as its new UK Head of Public Affairs, effective immediately.

Reset Health is excited to announce a strategic long term collaboration with Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics and specialist services. 

From reduced productivity and absenteeism to increased healthcare utilisation for associated conditions, obesity creates significant challenges for employers.

The aim of this service evaluation was to assess the impact of the Reset Health programme on weight, metabolic parameters, and other health-related outcomes at 12 and 24 weeks.

Roczen delivers individualised health programmes utilising time-restricted eating and a low refined carbohydrate, moderate protein diet to those with living with overweight, obesity, prediabetes and type 2 diabetes (T2DM).

Before we talk about obesity medications, it’s important to outline what obesity is and what happens inside the body.

We conducted a retrospective, real-world service evaluation. Patients were initiated on a 16-hour TRE plan with low-carbohydrate, moderate-protein dietary guidance.

Reset Health is pleased to announce the appointment of Sarah Le Brocq as its new UK Head of Public Affairs, effective immediately.

Reset Health, the experts in the personalised management of chronic disease, has entered a strategic partnership with Pharmacy2U, the UK’s largest online pharmacy, to deliver next-generation digital weight management support to patients using weight loss medication across the UK.

Obesity is a growing problem in the UK, affecting more and more people and putting a strain on both individuals and the healthcare system.

Reset Health, the experts in the personalised management of chronic disease, today announces Pinder Sahota has joined the Company as a member of its Advisory Board.

Reset Health is pleased to announce that Professor Sir Jonathan Van-Tam has joined Reset Health as a member of its Advisory Board.

Rochelle brings over 20 years of leadership experience in healthcare, spanning clinical innovation, digital transformation, and strategic product development.

We’re delighted to welcome David Plans who has joined Reset Health as Chief Scientific Officer (CSO).

Reset Health is excited to announce a strategic long term collaboration with Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics and specialist services. 

Nearly 26% of adult Britons live with obesity and this number is expected to rise to 37% by 2030.

Roczen delivers individualised health programmes utilising time-restricted eating and a low refined carbohydrate, moderate protein diet to those with living with overweight, obesity, prediabetes and type 2 diabetes (T2DM).

We conducted a retrospective, real-world service evaluation. Patients were initiated on a 16-hour TRE plan with low-carbohydrate, moderate-protein dietary guidance.

The aim of this service evaluation was to assess the impact of the Reset Health programme on weight, metabolic parameters, and other health-related outcomes at 12 and 24 weeks.

Obesity and type 2 diabetes (T2D) remain major global health challenges. Continuous energy restriction can help people lose weight, but more recently time-restricted eating (TRE) has been shown to be an alternative method for weight loss.

Obesity and depression are deeply interconnected, yet few programmes effectively address both in tandem. The Roczen Programme, developed by Reset Health Ltd., offers a fresh, clinically grounded approach.